• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受局限性前列腺癌根治性前列腺切除术的年轻男性的长期肿瘤学结局

Long-Term Oncological Outcomes for Young Men Undergoing Radical Prostatectomy for Localized Prostate Cancer.

作者信息

Milonas Daimantas, Venclovas Zilvinas, Gudinaviciene Inga, Zviniene Kristina, Matjosaitis Aivaras Jonas

机构信息

Department of Urology, Lithuanian University of Health Sciences, Medical Academy, A. Mickeviciaus 9, LT-44307 Kaunas, Lithuania.

Department of Pathology, Lithuanian University of Health Sciences, Medical Academy, A. Mickeviciaus 9, LT-44307 Kaunas, Lithuania.

出版信息

Biomed Res Int. 2017;2017:9858923. doi: 10.1155/2017/9858923. Epub 2017 Feb 19.

DOI:10.1155/2017/9858923
PMID:28299340
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5337309/
Abstract

. The aim of this study was to describe PCa characteristics and long-term outcomes in young men aged ≤55 years after radical prostatectomy (RP) and to compare them with older men cohort. . Among 2,200 patients who underwent RP for clinically localized PCa at our centre between 2001 and 2015, 277 (10.3%) men aged ≤55 years were identified. All preoperative and pathological parameters were compared between groups. Biochemical progression free survival (BPFS) and disease progression free survival (DPFS) were assessed at 5 and 10 years. . Men aged ≤55 years had similar pathological tumor characteristics and biochemical recurrence rate (BCR) compared to their older counterparts. Disease progression rate 2.5% versus 0.4% was higher in older patients ( = 0.026). BPFS rate was not different in both study groups. Estimated 10-year DPFS was 98.8% in younger men compared to 89.2% in their older counterparts ( = 0.031). Multivariate Cox regression showed that Gleason score lymph-nodes and surgical margins status were significant predictors for disease progression. . In our cohort, men aged ≤55 years had similar pathological PCa characteristics and BCR rate in comparison with older men. RP can be performed with excellent long-term DPFS results in men with localized PCa at ≤55 years of age.

摘要

本研究的目的是描述年龄≤55岁的年轻男性在根治性前列腺切除术(RP)后的前列腺癌特征和长期预后,并将其与老年男性队列进行比较。在2001年至2015年间于我们中心接受临床局限性前列腺癌RP治疗的2200例患者中,确定了277例(10.3%)年龄≤55岁的男性。对两组之间的所有术前和病理参数进行了比较。在5年和10年时评估了无生化进展生存期(BPFS)和无疾病进展生存期(DPFS)。年龄≤55岁的男性与老年男性相比,具有相似的病理肿瘤特征和生化复发率(BCR)。老年患者的疾病进展率为2.5%,而老年患者为0.4%(P = 0.026)。两个研究组的BPFS率没有差异。年轻男性的估计10年DPFS为98.8%,而老年男性为89.2%(P = 0.031)。多变量Cox回归显示,Gleason评分、淋巴结和手术切缘状态是疾病进展的重要预测因素。在我们的队列中,年龄≤55岁的男性与老年男性相比,具有相似的病理前列腺癌特征和BCR率。对于年龄≤55岁的局限性前列腺癌男性,RP可以取得优异的长期DPFS结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c424/5337309/c523d1fb0ca9/BMRI2017-9858923.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c424/5337309/1f370815e6b7/BMRI2017-9858923.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c424/5337309/c523d1fb0ca9/BMRI2017-9858923.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c424/5337309/1f370815e6b7/BMRI2017-9858923.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c424/5337309/c523d1fb0ca9/BMRI2017-9858923.002.jpg

相似文献

1
Long-Term Oncological Outcomes for Young Men Undergoing Radical Prostatectomy for Localized Prostate Cancer.接受局限性前列腺癌根治性前列腺切除术的年轻男性的长期肿瘤学结局
Biomed Res Int. 2017;2017:9858923. doi: 10.1155/2017/9858923. Epub 2017 Feb 19.
2
Radical prostatectomy represents an effective treatment in patients with specimen-confined high pathological Gleason score prostate cancer.根治性前列腺切除术是治疗标本中存在高病理 Gleason 评分前列腺癌的有效方法。
BJU Int. 2013 May;111(5):723-30. doi: 10.1111/j.1464-410X.2012.11114.x. Epub 2012 Apr 4.
3
Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.根治性前列腺切除术改善了 PSA 时代淋巴结阳性前列腺癌男性的无进展生存期和癌症特异性生存期:一项确认性研究。
BJU Int. 2011 Jun;107(11):1755-61. doi: 10.1111/j.1464-410X.2010.09730.x. Epub 2010 Oct 13.
4
Long-term oncological outcomes of men undergoing radical prostatectomy with preoperative prostate-specific antigen <2.5 ng/ml and 2.5-4 ng/ml.术前前列腺特异性抗原<2.5ng/ml 和 2.5-4ng/ml 的男性接受根治性前列腺切除术的长期肿瘤学结果。
Urol Oncol. 2013 Nov;31(8):1527-32. doi: 10.1016/j.urolonc.2012.06.003. Epub 2012 Jul 12.
5
Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.辅助治疗初治患者根治性前列腺切除术后切缘阳性对前列腺特异抗原失败的影响。
BJU Int. 2011 Jun;107(11):1748-54. doi: 10.1111/j.1464-410X.2010.09728.x. Epub 2010 Sep 30.
6
Aetiology and management of earlier vs later biochemical recurrence after retropubic radical prostatectomy.耻骨后根治性前列腺切除术后早期与晚期生化复发的病因及处理
BJU Int. 2017 Oct;120(4):505-510. doi: 10.1111/bju.13816. Epub 2017 Mar 14.
7
Patterns and predictors of early biochemical recurrence after radical prostatectomy and adjuvant radiation therapy in men with pT3N0 prostate cancer: implications for multimodal therapies.根治性前列腺切除术和辅助放疗后 pT3N0 前列腺癌患者早期生化复发的模式和预测因素:对多模式治疗的影响。
Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):960-7. doi: 10.1016/j.ijrobp.2013.09.015. Epub 2013 Oct 23.
8
Radical prostatectomy in very high-risk localized prostate cancer: long-term outcomes and outcome predictors.极高风险局限性前列腺癌的根治性前列腺切除术:长期疗效及疗效预测因素
Scand J Urol Nephrol. 2012 Jun;46(3):164-71. doi: 10.3109/00365599.2011.637956. Epub 2012 Feb 27.
9
Short (≤ 1 mm) positive surgical margin and risk of biochemical recurrence after radical prostatectomy.短(≤1 毫米)阳性切缘与根治性前列腺切除术后生化复发的风险。
BJU Int. 2013 Apr;111(4):559-63. doi: 10.1111/j.1464-410X.2012.11340.x. Epub 2012 Jul 3.
10
A Family History of Lethal Prostate Cancer and Risk of Aggressive Prostate Cancer in Patients Undergoing Radical Prostatectomy.接受根治性前列腺切除术患者的致命性前列腺癌家族史与侵袭性前列腺癌风险
Sci Rep. 2015 Jun 26;5:10544. doi: 10.1038/srep10544.

引用本文的文献

1
Aquaporins as Prognostic Biomarker in Prostate Cancer.水通道蛋白作为前列腺癌的预后生物标志物
Cancers (Basel). 2023 Jan 4;15(2):331. doi: 10.3390/cancers15020331.
2
Current Mental Distress Among Men With a History of Radical Prostatectomy and Related Adverse Correlates.有根治性前列腺切除术史的男性的当前精神困扰及相关不良关联。
Am J Mens Health. 2020 Sep-Oct;14(5):1557988320957535. doi: 10.1177/1557988320957535.
3
Significance of Time Until PSA Recurrence After Radical Prostatectomy Without Neo- or Adjuvant Treatment to Clinical Progression and Cancer-Related Death in High-Risk Prostate Cancer Patients.

本文引用的文献

1
Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer.前列腺癌监测、手术或放疗后的患者报告结局
N Engl J Med. 2016 Oct 13;375(15):1425-1437. doi: 10.1056/NEJMoa1606221. Epub 2016 Sep 14.
2
Prostate cancer in men aged less than 50 years at diagnosis.诊断时年龄小于50岁的男性前列腺癌。
World J Urol. 2016 Nov;34(11):1533-1539. doi: 10.1007/s00345-016-1824-4. Epub 2016 Apr 12.
3
Young-age prostate cancer.青年前列腺癌
高危前列腺癌患者在未接受新辅助或辅助治疗的情况下,前列腺癌根治术后至PSA复发时间对临床进展和癌症相关死亡的意义。
Front Oncol. 2019 Nov 22;9:1286. doi: 10.3389/fonc.2019.01286. eCollection 2019.
4
Age and aggressiveness of prostate cancer: analysis of clinical and pathological characteristics after radical prostatectomy for men with localized prostate cancer.前列腺癌的年龄与侵袭性:局限性前列腺癌男性患者根治性前列腺切除术后临床及病理特征分析
Cent European J Urol. 2019;72(3):240-246. doi: 10.5173/ceju.2019.1974. Epub 2019 Sep 16.
5
Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.比较质子束疗法与调强放疗在前列腺癌术后治疗中的毒性结果。
Cancer. 2019 Dec 1;125(23):4278-4293. doi: 10.1002/cncr.32457. Epub 2019 Sep 10.
6
Markers of epithelial-to-mesenchymal transition reflect tumor biology according to patient age and Gleason score in prostate cancer.上皮-间质转化标志物根据前列腺癌患者的年龄和 Gleason 评分反映肿瘤生物学特性。
PLoS One. 2017 Dec 4;12(12):e0188842. doi: 10.1371/journal.pone.0188842. eCollection 2017.
J Clin Pathol. 2015 Jul;68(7):511-5. doi: 10.1136/jclinpath-2015-202993. Epub 2015 Apr 2.
4
Prostate cancer risk prediction based on complete prostate cancer family history.基于完整前列腺癌家族病史的前列腺癌风险预测
Prostate. 2015 Mar 1;75(4):390-8. doi: 10.1002/pros.22925. Epub 2014 Nov 18.
5
Outcome of surgery in locally advanced pT3a prostate cancer.局部晚期pT3a前列腺癌的手术结果
Cent European J Urol. 2011;64(4):209-12. doi: 10.5173/ceju.2011.04.art4. Epub 2011 Dec 9.
6
Functional and oncological outcomes of patients aged <50 years treated with radical prostatectomy for localised prostate cancer in a European population.在欧洲人群中,接受根治性前列腺切除术治疗局限性前列腺癌的<50 岁以下患者的功能和肿瘤学结局。
BJU Int. 2014 Jul;114(1):38-45. doi: 10.1111/bju.12407. Epub 2013 Dec 2.
7
Recent trends in prostate cancer testing and incidence among men under age of 50.50 岁以下男性前列腺癌检测和发病的最新趋势。
Cancer Epidemiol. 2012 Apr;36(2):122-7. doi: 10.1016/j.canep.2011.10.014. Epub 2011 Nov 22.
8
Prostate cancer in men less than the age of 50: a comparison of race and outcomes.50 岁以下男性前列腺癌:种族与结局比较。
Urology. 2011 Jul;78(1):110-5. doi: 10.1016/j.urology.2010.12.046. Epub 2011 Mar 12.
9
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.
10
Outcome predictors of radical prostatectomy in patients with prostate-specific antigen greater than 20 ng/ml: a European multi-institutional study of 712 patients.前列腺特异性抗原大于 20ng/ml 患者根治性前列腺切除术的预后预测因素:来自欧洲 712 例患者的多机构研究。
Eur Urol. 2010 Jul;58(1):1-7; discussion 10-1. doi: 10.1016/j.eururo.2010.03.001. Epub 2010 Mar 17.